Cargando…
Surgical treatment in oligometastatic breast cancer
Metastatic breast cancer (MBC) management is based on systemic treatment (ST), while the local therapy role remains controversial. We present the case of a 36-year-old woman with a diagnosis of hormone receptor-positive and human epidermal growth factor receptor type 2-positive breast cancer and iso...
Autores principales: | Vargas, Catalina, Maiz, Cristóbal, Navarro, María Elena, Oddó, David, Sánchez, César, Bustos, Marisa, Camus, Mauricio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592707/ https://www.ncbi.nlm.nih.gov/pubmed/31281428 http://dx.doi.org/10.3332/ecancer.2019.931 |
Ejemplares similares
-
Breast lesions with atypia in percutaneous biopsies, managed with surgery in the last 10 years
por: Carrillo, Mitzy, et al.
Publicado: (2019) -
Mammography correlates to better survival rates in breast cancer patients: a 20-year experience in a University health institution
por: Maiz, Cristóbal, et al.
Publicado: (2020) -
Radiation therapy for oligometastatic oropharyngeal cancer
por: Martini, Stefania, et al.
Publicado: (2020) -
Proton Radiotherapy for Patients With Oligometastatic Breast Cancer Involving the Sternum
por: Johnson, Andrew, et al.
Publicado: (2021) -
Clinico-Pathologic Subtypes of Breast Cancer Primary Tumors Are Related to Prognosis after Recurrence
por: Sánchez, Cesar, et al.
Publicado: (2016)